Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on October 16, 2020, by Cellectis S.A., a foreign private issuer based in Paris, France, serves as a report of a material corporate event. The filing announces the scheduling of a Combined Ordinary and Extraordinary General Meeting of shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The primary material event is the confirmation of the upcoming shareholder meeting.
Guidance, Outlook, and Management Commentary
Management has confirmed the following details regarding the Combined Ordinary and Extraordinary General Meeting:
- Date: November 4, 2020
- Time: 9:30 a.m. (Paris time)
- Location: 8, rue de la Croix Jarry, 4th floor, 75013 Paris, France
The filing incorporates by reference several exhibits intended for holders of American Depositary Shares (ADS), including the Depositary's Notice, 2016 Voting Instructions, and a Q&A on voting procedures.
Key Facts for Investor Verification
- Verify the specific agenda items for the November 4, 2020, meeting by reviewing the attached exhibits (99.1, 99.2, 99.3).
- Confirm voting deadlines and procedures for ADS holders as outlined in the "Questions and Answers on Voting Procedures."
- Note that this filing contains no financial results; investors should refer to the most recent Form 20-F or quarterly reports for financial data.